Safety and immunogenicity of novel respiratory syncytial...

Safety and immunogenicity of novel respiratory syncytial virus (RSV) vaccines based on the RSV viral proteins F, N and M2-1 encoded by simian adenovirus (PanAd3-RSV) and MVA (MVA-RSV); protocol for an open-label, dose-escalation, single-centre, phase 1 clinical trial in healthy adults

Green, C A, Scarselli, E, Voysey, M, Capone, S, Vitelli, A, Nicosia, A, Cortese, R, Thompson, A J, Sande, C S, de Lara, Catherine, Klenerman, P, Pollard, A J
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
5
Language:
english
Journal:
BMJ Open
DOI:
10.1136/bmjopen-2015-008748
Date:
October, 2015
File:
PDF, 1.15 MB
english, 2015
Conversion to is in progress
Conversion to is failed